Moore Kuehn, PLLC Encourages Investors of AbbVie Inc. or International Business Machines Corporation to Contact Law Firm

<br /> Moore Kuehn, PLLC Encourages Investors of AbbVie Inc. or International Business Machines Corporation to Contact Law Firm<br />

PR Newswire

NEW YORK

,

April 13, 2022

/PRNewswire/ —

Moore Kuehn, PLLC, a securities and shareholder law firm located on Wall Street, is investigating potential claims against:

AbbVie Inc. (NYSE: ABBV)

The company, its officers, or directors misrepresented and/or failed to disclose that: (1) safety concerns about Xeljanz extended to Rinvoq and other JAK inhibitors; (2) as a result, it was likely that the FDA would require additional safety warnings for Rinvoq and would delay the approval of additional treatment indications for Rinvoq; and (3) therefore, Defendants’ statements about the company’s business, operations, and prospects lacked a reasonable basis. As a result of the alleged wrongful acts and omissions, AbbVie’s securities have experienced a significant decline in market value and AbbVie investors have suffered significant damages.

International Business Machines Corporation (NYSE: IBM)

Please contact only if you acquired shares

before

April 4, 2017

.

After the close of the market on October 16, 2018, IBM revealed a shortfall in revenue and disappointing 3Q2018 growth associated with the Company’s Strategic Imperatives and CAMSS lines of business, particularly its Cloud business line.

On

October 20, 2021

, after the close of the market, the Company issued a press release announcing its 3Q2021 results. The Company announced total revenues for the quarter of

$17.62 billion

, a shortfall of

$191.84 million

based on analyst estimates. The main culprit was the Cloud & Cognitive Software segment, which had revenues of

$5.69 billion

, a shortfall of approximately

$80 million

based on analyst estimates of

$5.77 billion

. Over 42% of the

$191 million

shortfall was attributable to the Company’s Cloud & Cognitive Software segment – where most of the strategic revenue produced by the fraudulent scheme and wrongful reclassification of revenues from non-strategic to strategic historically went.

Shareholders of ABBV or IBM should contact Fletcher Moore, Esq. by email at

[email protected]

or telephone at

(212) 709-8245

.

Moore Kuehn is a New York-based law firm with attorneys representing investors, stockholders, unitholders, and consumers. Attorney advertising. Prior results do not guarantee similar outcomes.

Moore Kuehn, PLLC

Fletcher Moore, Esq.

30 Wall Street, 8
^th
Floor

New York

, New York 10005

[email protected]

(212) 709-8245